PGP9.5 methylation as a marker for metastatic colorectal cancer.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 19035297)

Published in Anticancer Res on November 27, 2008

Authors

Hiroki Mizukami1, Atsushi Shirahata, Tetsuhiro Goto, Makiko Sakata, Mitsuo Saito, Kazuyoshi Ishibashi, Gaku Kigawa, Hiroshi Nemoto, Yutaka Sanada, Kenji Hibi

Author Affiliations

1: Department of Surgery, Showa University Fujigaoka Hospital, Yokohama 227-8501, Japan.

Articles citing this

The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling. Leukemia (2010) 1.15

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One (2011) 1.11

The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS One (2012) 1.06

Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes. PLoS One (2009) 1.02

Ubiquitin C-terminal hydrolase l1 in tumorigenesis. Biochem Res Int (2012) 0.93

Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma. J Transl Med (2009) 0.91

Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression. PLoS One (2013) 0.90

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clin Epigenetics (2012) 0.87

Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas. PLoS One (2015) 0.82

Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells. Neoplasia (2012) 0.81

The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer. Biomed Res Int (2015) 0.77

Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents. Int J Mol Sci (2015) 0.75

Articles by these authors

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg (2004) 2.18

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci (2003) 1.88

Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol (2004) 1.52

DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell (2002) 1.51

Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. J Gastroenterol (2005) 1.50

MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res (2011) 1.48

MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res (2010) 1.42

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg (2003) 1.21

PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res (2002) 1.21

MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res (2010) 1.21

Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res (2003) 1.15

Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res (2009) 1.13

Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res (2002) 1.09

Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Anticancer Res (2008) 1.04

Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol (2003) 1.01

Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer (2005) 0.99

To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother (2007) 0.99

Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain. Neurochem Res (2010) 0.99

Methylation of HACE1 in gastric carcinoma. Anticancer Res (2009) 0.99

TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis (2004) 0.97

High-level tryptophan accumulation in seeds of transgenic rice and its limited effects on agronomic traits and seed metabolite profile. J Exp Bot (2006) 0.96

Effects of gangliosides on ethanol-induced neurodegeneration in the developing mouse brain. Alcohol Clin Exp Res (2007) 0.96

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a phase II study following the learning curve. J Surg Oncol (2005) 0.96

Prediction of pancreatic fistula by amylase levels of drainage fluid on the first day after pancreatectomy. Hepatogastroenterology (2003) 0.96

Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology (2004) 0.95

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci (2006) 0.95

Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma. Jpn J Clin Oncol (2002) 0.95

Lithium blocks ethanol-induced modulation of protein kinases in the developing brain. Biochem Biophys Res Commun (2008) 0.94

[Study of perception gaps in pharmaceutical terms and related issues between laypeople and medical practitioners]. Nihon Eiseigaku Zasshi (2013) 0.93

Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients. J Gastroenterol (2004) 0.92

Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer. Anticancer Res (2010) 0.92

Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res (2002) 0.92

Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain. J Neurochem (2010) 0.91

Collision tumor of primary malignant lymphoma and adenocarcinoma in the colon: report of a case. Surg Today (2010) 0.91

Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett (2002) 0.91

Autoimmune thrombocytopenic purpura, autoimmune hemolytic anemia and gastric cancer appeared in a patient with myasthenia gravis. Intern Med (2006) 0.91

Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain. J Neurochem (2007) 0.91

Detection of TFPI2 methylation in the serum of gastric cancer patients. Anticancer Res (2011) 0.90

Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Jpn J Clin Oncol (2004) 0.90

Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. Alcohol Clin Exp Res (2005) 0.90

Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor. J Gastroenterol (2006) 0.90

PGP9.5 overexpression in esophageal squamous cell carcinoma. Hepatogastroenterology (2003) 0.90

Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett (2011) 0.89

TAOS1, a novel marker for advanced esophageal squamous cell carcinoma. Anticancer Res (2006) 0.89

Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. Anticancer Res (2007) 0.89

Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer. Cancer Sci (2004) 0.89

Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma. Anticancer Res (2009) 0.89